How IPA and partners mobilized to reach 100+ million with the NORM model.
View this email in your browser
[link removed]
[link removed]
More evidence, less poverty
[link removed]
John,
While access to vaccines is high in the United States, Europe, and other high-income and upper-middle-income countries, vaccination continues to be limited in low- and middle-income countries, and COVID-19 continues to disrupt the lives of millions.
In 2021, IPA and researchers from Yale and Stanford Medical School conducted the first randomized controlled trial that shows—in a real-world setting—that wearing masks, particularly surgical masks, reduces COVID-19.
IPA’s research
[link removed]
not only showed the effectiveness of masks in the fight against COVID-19 but also revealed that a combination of mask distribution and promotion campaigns (called the NORM model) tripled mask use.
IPA went beyond the research and partnered with decision-makers and organizations to support them in quickly scaling up the NORM model
[link removed]
. As of today, our partners are implementing the model in Bangladesh, India, Nepal, and Pakistan to reach 100 million people.
Watch this video
[link removed]
about how and why we took action to find out what works, and then helped ensure that evidence was used to improve—and save—lives.
Your contribution today will enable IPA to continue to produce evidence that improves and saves lives. Please consider a gift today.
Donate Now
[link removed]
Best wishes,
The IPA Team
[link removed]
[link removed]
[link removed]
DONATE
[link removed]
| RESEARCH
[link removed]
| IMPACT
[link removed]
| WORK WITH IPA
[link removed]
poverty-action.org
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
Sent to
[email protected] by Innovations for Poverty Action (IPA)
Innovations for Poverty Action
655 15th St. NW, Suite 800
Washington, DC xxxxxx
[email protected]
mailto:
[email protected]
Manage Your Email Preferences
[link removed]
| Forward This Email
[link removed]
